权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Small Bicyclic Amines: Unexplored Motifs for Drug Discovery

小双环胺：药物发现的未探索基序

基本信息

批准号：
2744581
负责人：
金额：
--
依托单位：
University of Leeds
依托单位国家：
英国
项目类别：
Studentship
财政年份：
2022
资助国家：
英国
起止时间：
2022 至无数据
项目状态：
未结题

来源：
https://gtr.ukri.org/projects?ref=studentship-2744581
关键词：
Small Bicyclic Amines Unexplored Motifs

项目摘要

Substituents and scaffolds that can beneficially alter physicochemical properties and/or explore novel vectors can have transformative potential in medicinal chemistry, delivering molecules with improved selectivity profiles and hence safer, more effective drugs. In this project, we introduce small bicyclic amines (SBAs) as unusual and underexplored motifs that, when linked to (hetero)aryl groups, remain pyramidalised at nitrogen. This not only creates new 3D vectors for exploration but also has a positive impact on the physicochemical and metabolic properties of the molecules, which can lead to more effective and selective drug molecules. In this programme, will introduce SBAs as a new motif for medicinal chemistry by (a) developing scalable chemical synthetic routes to SBAs; (b) optimising chemical catalytic methods for their arylation; (c) characterising and understanding physicochemical and structural properties of arylated SBAs, including the use of data-driven approaches to understand and predict properties; and (d) demonstrating positive impact on the properties of small molecule bioactives.The work directly addresses challenges in improving human health and so addresses the EPSRC theme of Healthcare Technologies, specifically the grand challenge of "developing new therapies". It contains technical elements relevant to EPSRC research areas of Chemical Biology and Biological Chemistry, Synthetic Organic Chemistry and Catalysis.

可以有益地改变物理化学性质和/或探索新型载体的取代基和支架可以在药物化学中具有变革潜力，以改善的选择性特征递送分子，从而更安全，更有效的药物。在这个项目中，我们引入了小双环胺（SBAs）作为不寻常的和未被探索的图案，当连接到（杂）芳基基团时，保持在氮原子上的取代。这不仅为探索创造了新的3D载体，而且对分子的物理化学和代谢特性产生了积极的影响，从而可以产生更有效和更有选择性的药物分子。在这一计划中，将引入SBAs作为药物化学的一个新主题，通过（a）开发SBAs的可扩展化学合成路线;（B）优化其芳基化的化学催化方法;（c）表征和理解芳基化SBAs的物理化学和结构特性，包括使用数据驱动的方法来理解和预测特性;以及（d）展示对小分子生物活性物质的性质的积极影响。这项工作直接解决了改善人类健康的挑战，因此解决了EPSRC医疗保健技术的主题，特别是“开发新疗法”的巨大挑战。它包含与EPSRC化学生物学和生物化学，合成有机化学和催化研究领域相关的技术要素。